Manzo Pharmaceuticals, Inc. (MNZO)

Market Cap	109.95K -83.3%
Revenue (ttm)	n/a +2.2%
Net Income	7.75M
EPS	1.91
Shares Out	1.10B
PE Ratio	0.00
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	25,002
Average Volume	336,128
Open	0.0001
Previous Close	n/a
Day's Range	0.0001 - 0.0001
52-Week Range	n/a
Beta	-52.76
RSI	56.48
Earnings Date	n/a

About Manzo Pharmaceuticals

Manzo Pharmaceuticals, Inc., a specialty pharmaceutical company, engages in the research, development, and testing of patented and non-patented solutions and remedies. The company is involved in developing Lacto-Freedom, a patented probiotic, which aids in the digestion of lactose containing foods primarily for people with lactose intolerance; and a natural remedy for colic in babies. It was formerly known as Fortune Oil & Gas, Inc. and changed its name to Manzo Pharmaceuticals, Inc. in September 2014. Manzo Pharmaceuticals, Inc. was incorporat...

• Industry: Shell Companies
• Sector: Financials
• Founded: 1980
• Employees: 12
• Stock Exchange: OTCMKTS
• Ticker Symbol: MNZO